DRC and WHO are moving to expedite the launch of a multi-armed Phase 3 Ebola vaccine trial.
Moderna launches an early-stage Ebola mRNA vaccine trial; the piece also highlights Novo Nordisk and Eli Lilly earnings and Aurora Therapeutics staff cuts in a STAT+ exclusive biotech news round-up.
Ebola outbreak nears milestone with a vaccine months away, plus regulatory moves like FTC suiting Hims and Medicaid work rules.
WHO declares Ebola outbreak a Global Health Emergency (PHEIC).
Subscribe for real-time topic updates and unlimited access to our intelligence platform.